EVERTEC (EVTC) Competitors

Medpace (NASDAQ:MEDP) and EVERTEC (NYSE:EVTC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings, media sentiment and community ranking.

Do insiders & institutionals have more ownership in MEDP or EVTC?

78.0% of Medpace shares are held by institutional investors. Comparatively, 96.8% of EVERTEC shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.6% of EVERTEC shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, MEDP or EVTC?

Medpace has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, EVERTEC has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.

Does the MarketBeat Community favor MEDP or EVTC?

Medpace received 66 more outperform votes than EVERTEC when rated by MarketBeat users. Likewise, 62.81% of users gave Medpace an outperform vote while only 59.30% of users gave EVERTEC an outperform vote.

Company	Underperform	Outperform
Medpace	Outperform Votes 353 62.81%	Underperform Votes 209 37.19%
EVERTEC	Outperform Votes 287 59.30%	Underperform Votes 197 40.70%

Does the media prefer MEDP or EVTC?

In the previous week, Medpace had 8 more articles in the media than EVERTEC. MarketBeat recorded 20 mentions for Medpace and 12 mentions for EVERTEC. Medpace's average media sentiment score of 1.54 beat EVERTEC's score of 0.86 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	16 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
EVERTEC	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MEDP or EVTC more profitable?

Medpace has a net margin of 19.17% compared to EVERTEC's net margin of 10.20%. Medpace's return on equity of 51.48% beat EVERTEC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	19.17%	51.48%	20.47%
EVERTEC	10.20%	33.01%	8.85%

Do analysts rate MEDP or EVTC?

Medpace presently has a consensus price target of $349.30, suggesting a potential upside of 18.10%. EVERTEC has a consensus price target of $40.00, suggesting a potential upside of 5.86%. Given Medpace's higher probable upside, equities analysts clearly believe Medpace is more favorable than EVERTEC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
EVERTEC	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Which has preferable valuation & earnings, MEDP or EVTC?

Medpace has higher revenue and earnings than EVERTEC. EVERTEC is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.16B	3.94	$404.39M	$13.10	22.58
EVERTEC	$868.96M	2.77	$79.72M	$1.99	18.99

Summary

Medpace beats EVERTEC on 14 of the 17 factors compared between the two stocks.